Novartis Pharma Schweiz AG - Tabrecta 200 mg, Filmtabletten | | 67648 | | 02 | | Tabrecta 200 mg | | Filmtabletten | | L01EX17 | | Capmatinib | | 26.04.2021 | | |
| Composition | capmatinibum 200 mg ut capmatinibi hydrochloridum monohydricum, cellulosum microcristallinum, mannitolum, crospovidonum, povidonum K 30, magnesii stearas, silica colloidalis anhydrica, natrii laurilsulfas corresp. natrium 0.16 mg, Überzug: hypromellosum, E 171, macrogolum 4000, talcum, E 172 (flavum), pro compresso obducto. | Packungsbestandteile | | Coated tablets | | | Active Agent | Dose |
---|
Capmatinibum | 200 mg |
| BAG: Active Agent | Dose |
---|
Capmatinibum | 200 mg |
| | Inactive agents | Dose | additional_information |
---|
(Flavum) | | | Cellulosum Microcristallinum | | | Crospovidonum | | | E 171 | | color. | E 172 | | color. | Hypromellosum | | Überzug | Macrogol | 4000 | | Magnesii Stearas | | | Mannitol | | | Natrii Laurilsulfas | | | Povidonum K | 30 | | Pro Compresso Obducto | | | Silica Colloidalis Anhydrica | | | Talcum | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
002 | 120 | 5503.34 | 5954.25 | A | SL | Yes |
|
|